Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 14625701000001117 | Magnesium alginate (substance) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 14625801000001114 | Magnesium alginate | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Has active ingredient | False | Magnesium alginate | Inferred relationship | Existential restriction modifier | |
| Generic Algicon chewable tablets | Has active ingredient | False | Magnesium alginate | Inferred relationship | Existential restriction modifier | |
| Generic Algicon suspension sugar free | Has active ingredient | False | Magnesium alginate | Inferred relationship | Existential restriction modifier | |
| Algicon suspension (Aventis Pharma) | Has active ingredient | False | Magnesium alginate | Inferred relationship | Existential restriction modifier | |
| Gaviscon Infant oral powder sachets (Reckitt Benckiser Plc) | Has active ingredient | False | Magnesium alginate | Inferred relationship | Existential restriction modifier | |
| Algicon chewable tablets (Aventis Pharma) | Has active ingredient | False | Magnesium alginate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR